Literature DB >> 23347199

High prevalence of rheumatic heart disease in schoolchildren detected by echocardiography screening in New Caledonia.

Noémie Baroux1, Bernard Rouchon, Bertrand Huon, Agnès Germain, Jean-Michel Meunier, Eric D'Ortenzio.   

Abstract

AIM: Despite the well-documented burden of rheumatic heart disease (RHD) in several Pacific countries, the disease is poorly understood in New Caledonia. The aim of this study was to assess the prevalence of RHD detected by echocardiographic screening in school children.
METHODS: An annual RHD screening programme is conducted by the Health and Social Agency of New Caledonia for school-aged children in their fourth year of primary school. For the purpose of this study, we used data collected during this echocardiographic screening between 2008 and 2010.
RESULTS: Of 12,728 children screened, 50.2% were male and the mean age was 9.6 ± 0.6 years. Between 2008 and 2010, 114 children had RHD, corresponding to a prevalence of 8.9 cases per 1000 (95% confidence interval (CI) (7.3-10.6)). Prevalence of RHD was higher on the main island outside Greater Noumea (13.7 per 1000; 95% CI (9.8-17.5)) and in the outlying island groups (14.6 per 1000; 95% CI (8.4-20.9)) than in Greater Noumea (5.8 per 1000; 95% CI (4.1-7.5)). RHD was more prevalent in Melanesian children (13.5 per 1000; 95% CI (10.9-16.1)) than in European (1.8 per 1000; 95% CI (0.4-3.1)).
CONCLUSION: This study documented a high prevalence of RHD in New Caledonia, particularly in districts located outside Noumea and in children of Melanesian heritage. These results uncover a hitherto unknown burden of disease in New Caledonia and underline the importance of delivering secondary prophylaxis to reduce the prevalence of RHD.
© 2013 The Authors. Journal of Paediatrics and Child Health © 2013 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Mesh:

Year:  2013        PMID: 23347199     DOI: 10.1111/jpc.12087

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  7 in total

1.  Echocardiographic screening for rheumatic heart disease-some answers, but questions remain.

Authors:  Marc G W Rémond; Graeme P Maguire
Journal:  Transl Pediatr       Date:  2015-07

Review 2.  Sex Differences in Pediatric Rheumatology.

Authors:  Marco Cattalini; Martina Soliani; Maria Costanza Caparello; Rolando Cimaz
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

3.  Prevalence of rheumatic heart disease among school children in East Africa: a systematic review and meta-analysis.

Authors:  Melaku Bimerew; Biruk Beletew; Addisu Getie; Adam Wondmieneh; Getnet Gedefaw; Asmamaw Demis
Journal:  Pan Afr Med J       Date:  2021-03-08

Review 4.  Health Challenges of the Pacific Region: Insights From History, Geography, Social Determinants, Genetics, and the Microbiome.

Authors:  Paul F Horwood; Arnaud Tarantola; Cyrille Goarant; Mariko Matsui; Elise Klement; Masahiro Umezaki; Severine Navarro; Andrew R Greenhill
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

5.  Prevalence and progression of rheumatic heart disease: a global systematic review and meta-analysis of population-based echocardiographic studies.

Authors:  Jean Jacques Noubiap; Valirie N Agbor; Jean Joel Bigna; Arnaud D Kaze; Ulrich Flore Nyaga; Bongani M Mayosi
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

6.  Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study.

Authors:  Brunelle Gasse; Noémie Baroux; Bernard Rouchon; Jean-Michel Meunier; Isabelle De Frémicourt; Eric D'Ortenzio
Journal:  BMC Public Health       Date:  2013-02-12       Impact factor: 3.295

7.  Screening Rheumatic Heart Disease in 1530 New Caledonian Adolescents.

Authors:  Jean-Claude Chatard; Thomas Dubois; Florian Espinosa; Joël Kamblock; Pierre-Henri Ledos; Emmanuel Tarpinian; Antoine Da Costa
Journal:  J Am Heart Assoc       Date:  2020-04-26       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.